Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
CELC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

28.66

Margin Of Safety %

Put/Call OI Ratio

1

EPS Next Q Diff

-0.32

EPS Last/This Y

0.02

EPS This/Next Y

4.73

Price

92.74

Target Price

163.55

Analyst Recom

1

Performance Q

-29.01

Upside

-247.1%

Beta

0.2

Ticker: CELC



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-14CELC110.740.802.5433248
2026-07-15CELC91.430.961.0338224
2026-07-16CELC88.20.980.9140540
2026-07-17CELC88.440.740.2537037
2026-07-20CELC88.090.981.0225247
2026-07-21CELC91.70.990.1425767
2026-07-22CELC90.140.991.4225869
2026-07-23CELC88.231.001.0026069
2026-07-24CELC82.521.010.9326375
2026-07-27CELC82.11.021.0826420
2026-07-28CELC82.421.011.1126461
2026-07-29CELC83.31.001.4126432
2026-07-30CELC86.81.010.0326444
2026-07-31CELC86.40.990.0026591
2026-08-03CELC87.790.990.4026602
2026-08-04CELC92.480.990.2326645
2026-08-05CELC92.930.991.3326803
2026-08-06CELC93.341.000.4726910
2026-08-07CELC92.771.000.2926925
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-14CELC110.91-5.4- -3.53
2026-07-15CELC91.58-5.4- -3.53
2026-07-16CELC88.23-5.4- -3.53
2026-07-17CELC88.33-5.4- -3.53
2026-07-20CELC88.01-16.1- -3.53
2026-07-21CELC91.73-16.1- -3.77
2026-07-22CELC90.14-16.1- -3.77
2026-07-23CELC88.29-16.1- -3.77
2026-07-24CELC82.63-16.1- -3.77
2026-07-27CELC82.24-16.1- -3.77
2026-07-28CELC82.34-16.1- -3.77
2026-07-29CELC83.25-16.1- -3.77
2026-07-30CELC87.63-16.1- -3.77
2026-07-31CELC86.36-16.1- -3.77
2026-08-03CELC87.85-16.1- -3.77
2026-08-04CELC87.85-16.1- -3.77
2026-08-05CELC92.91-16.1- -3.77
2026-08-06CELC93.33-16.1- -3.77
2026-08-07CELC92.74-16.1- -3.77
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1



19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-14CELC-0.58-4.0828.19
2026-07-15CELC-0.58-4.0828.19
2026-07-16CELC-0.58-4.0828.19
2026-07-17CELC-24.26-4.0828.19
2026-07-20CELC-24.26-4.1228.19
2026-07-21CELC-24.26-4.1228.19
2026-07-22CELC-24.26-4.1228.19
2026-07-23CELC-24.26-4.1228.19
2026-07-24CELC-24.26-4.1228.19
2026-07-27CELC-24.26-4.0528.66
2026-07-28CELC-24.26-4.0528.66
2026-07-29CELC-24.26-4.0528.66
2026-07-30CELC-24.14-4.0528.66
2026-07-31CELC-24.14-4.0528.66
2026-08-03CELC-24.14-6.1028.66
2026-08-04CELC-24.14-6.1028.66
2026-08-05CELC-24.14-6.1028.66
2026-08-06CELC-24.14-6.1028.66
2026-08-07CELC-24.14-6.1028.66
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

-0.86

Avg. EPS Est. Current Quarter

-1.08

Avg. EPS Est. Next Quarter

-1.18

Insider Transactions

-24.14

Institutional Transactions

-6.1

Beta

0.2

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

6

Fair Value

Quality Score

4

Growth Score

23

Sentiment Score

90

Actual DrawDown %

38.6

Max Drawdown 5-Year %

-76.3

Target Price

163.55

P/E

Forward P/E

PEG

P/S

P/B

83.81

P/Free Cash Flow

EPS

-3.9

Average EPS Est. Cur. Y​

-3.77

EPS Next Y. (Est.)

0.96

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.35

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.24

EBIT Estimation

◆ CELC Healthcare
$92.79
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
16/20
Pullback
19/25
Volume
11/15
Valuation
12/20
TP/AR
4/10
Options
3/10
RSI
49.5
Range 1M
34.2%
Sup Dist
1.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
27 /100
WEAK
Momentum
7/25
Growth
11/30
Estimates
2/20
Inst/Vol
1/15
Options
6/10
EPS Yr
-11.2%
EPS NY
88%
52W%
44.3%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🔴 SELL -23.8% upside
Quality
2/30
Valuation
0/30
Growth
8/25
Stability
5/10
LT Trend
3/5
Upside
-23.8%
Quality
4
Click a card to see score breakdown Full Analysis →
CELC — P/E HistoricalDiagnostics & Research
Celcuity Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 155
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.
CELC

Latest News

—
Caricamento notizie per CELC…
stock quote shares CELC – Celcuity Inc. Stock Price stock today
news today CELC – Celcuity Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CELC – Celcuity Inc. yahoo finance google finance
stock history CELC – Celcuity Inc. invest stock market
stock prices CELC premarket after hours
ticker CELC fair value insiders trading